On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Daiichi Sankyo (United States)

InstitutionResearch output, impact & collaborations

Daiichi Sankyo (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Daiichi Sankyo (United States)?

ScholarIQrecord summary

Daiichi Sankyo (United States) is a research organisation in Parsippany, US. OpenAlex records 2,423 works and 261,680 citations for it. 824 researchers list it as their most recent affiliation.

How many works does Daiichi Sankyo (United States) have?

ScholarIQindexed works

Daiichi Sankyo (United States) has 2,423 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Daiichi Sankyo (United States) →

How many citations does Daiichi Sankyo (United States) have?

ScholarIQcitation count

Daiichi Sankyo (United States) has 261,680 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Daiichi Sankyo (United States) →

How many researchers are at Daiichi Sankyo (United States)?

ScholarIQresearcher count

Daiichi Sankyo (United States) has 824 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Daiichi Sankyo (United States)?

ScholarIQavg h-index

Daiichi Sankyo (United States) has an average h-index of 53 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Daiichi Sankyo (United States)?

ScholarIQror

The ROR for Daiichi Sankyo (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Daiichi Sankyo (United States)?

ScholarIQopenalex

The OpenAlex for Daiichi Sankyo (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Daiichi Sankyo (United States)?

ScholarIQtop researchers by citations

Richard W. Joseph · Cancer Immunotherapy and Biomarkers

282 works25,942 citations

What are the most-cited papers on Daiichi Sankyo (United States)?

ScholarIQmost cited works

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer

The Lancet. 20163,735 Citations

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

David F. McDermott, Mahrukh Huseni, Michael B. Atkins, Robert J. Motzer, Brian I. Rini, Bernard Escudier, Lawrence Fong, Richard W. Joseph, Sumanta K. Pal, James A. Reeves, Mario Sznol, John D. Hainsworth, W. Kimryn Rathmell, Walter M. Stadler, Thomas E. Hutson, Martin Gore, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Riccardo Danielli, Viktor Gruenwald, Toni K. Choueiri, Dorothee Nickles, Suchit Jhunjhunwala, Elisabeth Piault‐Louis, Alpa Thobhani, Jiaheng Qiu, Daniel S. Chen, Priti S. Hegde, Christina Schiff, Gregg Fine, Thomas Powles

Nature Medicine. 20181,263 CitationsOPEN ACCESS

High response rate to PD-1 blockade in desmoplastic melanomas

Zeynep Eroglu, Jesse M. Zaretsky, Siwen Hu‐Lieskovan, Dae Won Kim, Alain P. Algazi, Douglas B. Johnson, Elizabeth Liniker, Benjamin Y. Kong, Rodrigo Ramella Munhoz, Suthee Rapisuwon, Pier Federico Gherardini, Bartosz Chmielowski, Xiaoyan Wang, I. Peter Shintaku, Cody Wei, Jeffrey A. Sosman, Richard W. Joseph, Michael A. Postow, Matteo S. Carlino, Wen-Jen Hwu, Richard A. Scolyer, Jane L. Messina, Alistair J. Cochran, Georgina V. Long, Antoni Ribas

Nature. 2018333 CitationsOPEN ACCESS

How much of the research on Daiichi Sankyo (United States) is open access?

ScholarIQopen access share

67%OPEN ACCESS

Gold

Green

67%

Hybrid

Bronze

Closed

33%